Sanofi
CIK 1121404 · last filed 2021-09-14
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$3.17B
Companies
11
Total Filings
65
Lifetime Open-Market Net
-$2.44B
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| TBIO | 10%+ Owner | 55,152,046 | $0.00 | $5.5K | $2.74B | 1 | 2021-09-14 |
| Icosavax, Inc. (ICVX) Delisted | 10%+ Owner | 3,155,169 | $15.31 | $48.31M | $1.00M | 1 | 2021-08-02 |
| Inozyme Pharma, Inc. (INZY) Delisted | 10%+ Owner | 438,875 | $4.00 | $1.76M | $1.30M | 1 | 2020-07-29 |
| REGN | 10%+ Owner | 279,766 | $612.14 | $171.26M | -$9.52B | 46 | 2020-06-11 |
| FULC | 10%+ Owner | 464,285 | $3.45 | $1.60M | $1.50M | 1 | 2019-07-23 |
| MyoKardia, Inc. (MYOK) Delisted | 10%+ Owner | 0 | — | — | -$121.48M | 5 | 2019-02-15 |
| ALNY | 10%+ Owner | 10,554,134 | $282.85 | $2.99B | $1.98B | 6 | 2017-06-01 |
| VYGR | 2,352,941 | $3.50 | $8.24M | $1.75M | 1 | 2015-11-18 | |
| Regulus Therapeutics Inc. (RGLS) Delisted | 10%+ Owner | 5,053,779 | $8.16 | $41.24M | $10.00M | 1 | 2014-02-05 |
| HUMANIGEN, INC (KBIO) Delisted | 579,030 | — | — | $700.0K | 1 | 2013-02-07 | |
| GENZYME CORP (GENZ) Delisted | 10%+ Owner | 187,986,225 | — | — | $2.48B | 1 | 2011-04-08 |
Recent Filings · Page 7 of 7
65 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2014-02-05 | Regulus Therapeutics Inc. (RGLS) Delisted | Buy (P) | +1,303,780 | $10.00M | EDGAR |
| 2014-02-04 | REGN | Buy (P) | +208,972 | $59.30M | EDGAR |
| 2014-01-29 | REGN | Buy (P) | +157,920 | $43.57M | EDGAR |
| 2013-02-07 | HUMANIGEN, INC (KBIO) Delisted | Mixed | +87,500 | $700.0K | EDGAR |
| 2011-04-08 | GENZYME CORP (GENZ) Delisted | Buy (P) | +139,040,350 | $2.48B | EDGAR |
Showing 61–65 of 65
Prev
Page 7 of 7
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.